AOP Health in the news
Rare Diseases Solutions Worldwide
Tamtam found 20 recent articles about AOP Health.
- AOP Health standardisiert Veeva Industry Cloud for Life Sciences in allen Geschäftsbereichen
AOP Health is standardizing Veeva Industry Cloud across its operations to streamline processes and accelerate delivery of therapies for rare diseases and intensive care.
- Enoumena Therapeutics and AOP Health Announce Exclusive Canadian Commercialization Agreement for SIBBORAN(R) (landiolol)
Enoumena Therapeutics and AOP Health have partnered for the exclusive commercialization of the heart rate control drug SIBBORAN (landiolol) in Canada.
- Europe needs greater awareness of rare diseases
Public awareness of rare diseases in Europe is significantly low, leading to diagnostic challenges for millions affected, as highlighted by AOP Health's 30th anniversary survey.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
AOP Health won an arbitration award of approximately EUR 112 million against PharmaEssentia for intentional breaches and excessive pricing related to the drug BESREMi®.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi Proceedings
An ICC Arbitral Tribunal has issued a quantum award in favor of AOP Health concerning BESREMi proceedings.
- Un Tribunal Arbitral de la CCI emite un laudo sobre la cuantía a favor de AOP Health en un procedimiento por BESREMi
An international arbitration tribunal ordered PharmaEssentia Corp. to pay AOP Health approximately 112 million euros for contractual breaches and overcharging related to their BESREMi® license agreement.
- Das ICC-Schiedsgericht erlässt einen Schiedsspruch zur Höhe des Schadenersatzes zugunsten von AOP Health im BESREMi®-Verfahren
AOP Health was awarded approximately 112 million EUR in damages by an ICC arbitration court due to PharmaEssentia's intentional breach of contract and inflated pricing for BESREMi®.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
An ICC Arbitral Tribunal awarded AOP Health approximately EUR 112 million from PharmaEssentia due to intentional breaches and excessive pricing related to the BESREMi® agreement.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
AOP Health was awarded approximately EUR 112 million by an ICC Arbitral Tribunal against PharmaEssentia for intentional contractual breaches and excessive pricing of BESREMi®.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
An ICC Arbitral Tribunal awarded AOP Health approximately EUR 112 million from PharmaEssentia for intentional breaches and excessive pricing related to BESREMi®.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
An ICC Arbitral Tribunal awarded AOP Health approximately 112 million from PharmaEssentia for intentional contractual breaches and excessive pricing related to BESREMi®.
- ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings
An ICC Arbitral Tribunal awarded AOP Health approximately EUR 112 million in damages and overpayment reimbursements from PharmaEssentia Corp. for intentional breaches and excessive pricing related to BESREMi®.
- Why AI Readiness Starts with the Digital Foundation
AOP Health transitioned from fragmented, paper-based systems to a unified industry cloud to enhance scalability, efficiency, and establish a robust digital foundation for future AI initiatives.
- Trefelik gratuliert Exportpreisträgern im Handel – mnews
AOP Orphan Pharmaceuticals has been awarded the Gold Export Award by the Austrian Economic Chamber for its global success in rare disease therapies.
- Innovation aus Wien als Wirtschaftsmotor: AOP Health erhielt WKO-Exportpreis in Gold
AOP Health, an Austrian pharmaceutical company specializing in rare diseases, received the WKO Gold Export Award 2026, highlighting its international success, significant revenue, and job creation in Vienna.
- WKÖ-Trefelik gratuliert zu hervorragenden Exportleistungen im österreichischen Handel
AOP Orphan Pharmaceuticals, CONA Solar, and Sherpa Connection Systems received Austrian Export Awards for their strong international sales in specialized pharmaceuticals, solar air collectors, and timber construction systems.
- AOP Health and VRG Therapeutics partner on immunology program
A strategic partnership with VRG Therapeutics to develop a new potassium channel inhibitor for immunology indications.
- AOP Health, VRG Therapeutics Unite to Advance Inflammation and Immunology Target
AOP Health and VRG Therapeutics are collaborating on a novel Kv1.3 potassium channel inhibitor for inflammation and immunology using miniprotein technology.
- Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health
The Frankfurt Higher Regional Court confirmed a legal victory for AOP Orphan Pharmaceuticals, upholding an arbitral award against PharmaEssentia regarding the drug BESREMi®.
- Das Oberlandesgericht Frankfurt bestätigt den BESREMi®-Schiedsspruch zugunsten von AOP Health
The Higher Regional Court of Frankfurt confirmed a legal victory for AOP Health in a long-standing contract and damages dispute regarding the rare disease treatment BESREMi.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like AOP Health?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies